메뉴 건너뛰기




Volumn 45, Issue 4, 2002, Pages 888-893

Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV

Author keywords

[No Author keywords available]

Indexed keywords

AL 6619; AL 6629; AL 8520; BRINZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE II INHIBITOR; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE IV INHIBITOR; SULFONAMIDE; THIENO[3,2 E] 1,2 THIAZINE 6 SULFONAMIDE 2 (3 HYDROXYPHENYL) 3 (4 MORPHOLINYLMETHYL) 1,1 DIOXIDE; THIENO[3,2 E] 1,2 THIAZINE 6 SULFONAMIDE 2 (3 METHOXYPHENYL) 3 (4 MORPHOLINYLMETHYL) 1,1 DIOXIDE; THIENO[3,2 E] 1,2 THIAZINE 6 SULFONAMIDE 4 AMINO 3,4 DIHYDRO 2 (3 METHOXYPROPYL) 1,1 DIOXIDE; THIENO[3,2 E] 1,2 THIAZINE 6 SULFONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0037075147     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010163d     Document Type: Article
Times cited : (48)

References (31)
  • 5
    • 0001147656 scopus 로고
    • Comparative chemistry of aqueous humor in posterior and anterior chambers of rabbit eye
    • (1953) Arch. Ophthalmol. , vol.50 , pp. 401-417
    • Kinsey, V.E.1
  • 6
    • 0023224380 scopus 로고
    • Carbonic anhydrase: General perspectives and advances in glaucoma research
    • (1987) Drug Dev. Res. , vol.10 , pp. 255-276
    • Maren, T.H.1
  • 9
    • 0002898371 scopus 로고
    • Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox
    • (1954) Am. J. Ophthalmol. , vol.37 , pp. 13-15
    • Becker, B.1
  • 12
    • 33749223056 scopus 로고    scopus 로고
    • A triple-masked, primary therapy study of the efficacy and safety of BID and TID-dosed Brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% and BID timolol 0.5%
    • The Brinzolamide Primary Therapy Study Group
    • (1997) Invest. Ophthalmol. Visual Sci. , vol.38
    • Camras, C.B.1
  • 14
    • 33749204521 scopus 로고    scopus 로고
    • A triple-masked, placebo-controlled, adjunctive therapy study of the efficacy and safety of TID-dosed Brinzolamide 1.0% compared to the TID-dosed placebo when used adjunctively to timolol 0.5%
    • The Brinzolamide Adjunctive Therapy Group
    • (1997) Invest. Ophthalmol. Visual Sci. , vol.38
    • Shin, D.H.1
  • 15
    • 0000658597 scopus 로고    scopus 로고
    • The ocular comfort of TID-dosed Brinzolamide 1.0% compared to TID-dosed dorzolamide 2.0% in patients with primary open-angle glaucoma or ocular hypertension
    • The Brinzolamide Comfort Study Group
    • (1997) Invest. Ophthalmol. Visual Sci. , vol.38
    • Stewart, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.